Menu
As a physician scientist, I am devoted to improving patient care in endocrinology and advancing biomedical sciences. With my advanced training in molecular and cell biology, I strive to translate cutting-edge biotechnology innovation into potential applications in patient care. Current research projects include tissue engineering for generating insulin-producing cells for treatment of diabetes, and identification of novel agents and drug targets for tackling cell senescence. I am also involved in clinical trials sponsored by pharmaceutical industries.
| Li M, Marquez RC, Vinales KL, Reaven PD, Behari G, Dildeep A, and Harman SM. Considerations for Thyroid Fine Needle Aspiration Biopsies during the COVID-19 pandemic. Clinical Thyroidology. Apr 2020.156-158. |
| Nuotio-Antar AM, Poungvarin N, Li M, Schupp M, Mohammad M, Gerard S, Zou F, Chan L. FABP4-Cre Mediated Expression of Constitutively Active ChREBP Protects Against Obesity, Fatty Liver, and Insulin Resistance. Endocrinology. 2015 Nov;156(11):4020-32. doi: 10.1210/en.2015-1210. Epub 2015 Aug 6. |
| Imamura M, Chang BH, Kohjima M, Li M, Hwang B, Taegtmeyer H, Harris RA, and Chan L (2014). MondoA Deficiency Enhances Sprint Performance in Mice. Biochem. J. 464(1):35-48 |
| Li MV*, Shukla D, Rhodes B, Lall A, Shu J, Moriarity B, Largaespada D (2014). HomeRun Vector Assembly System: a flexible and standardized cloning system for multimodular DNA constructs. PLOS one, 9(6): e100948. (* Corresponding Author) |
| Poungvarin N, Lee JK, Yechoor VK, Li MV, Assavapokee T, Suksaranjit P, Thepsongwajja JJ, Saha PK, Oka K, Chan L (2012). Carbohydrate response element-binding protein (ChREBP) plays a pivotal role in beta cell glucotoxicity. Diabetologia, 55(6):1783-96 |
Interested in learning more about the Foundation and its operations? Head on over to the Career tab or send us an email!
